Feel better, look better, and take control of your healthfrom the comfort of your home
What Is PT-141 Spray (Bremelanotide)
faynutrition.com Everyday Health
A Morgan Stanley AlphaWise survey of senior human resources executives showed that the percentage of employers covering GLP-1s for obesity rose from 44% in 2024 to 48% last year, with respondents projecting it to reach 65% by 2027
People with Obesity: Individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher with weight-related health issues, can benefit from the weight loss effects of semaglutide
Both tirzepatide and semaglutide were associated with increased risk of gastrointestinal adverse events compared with placebo at all doses, tirzepatide 15mg was associated with the highest risk for nausea (3.6 times), vomiting (4.4 times) and diarrhoea (2.0 times)